Tech Company Financing Transactions
RxAdvance Funding Round
RxAdvance closed a $50 million financing round on 10/6/2018. Investors included private investors.
Transaction Overview
Company Name
Announced On
10/6/2018
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 1 investor participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
2 Park Central Dr.
Southborough, MA 01772
USA
Southborough, MA 01772
USA
Phone
Website
Email Address
Overview
The Pharmacy Benefit Management industry is known for 'business as usual' and has been challenged to bring real value to plan sponsors in addition to traditional transaction management such as benefit design, formulary and MAC management, rebate management, network contracting, and customer service.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ravi Ika
Chief Financial Officer
John Jacobsen
Chief Operating Officer
Madu Narahari
Chief Technical Officer
Prakash Tallabattula
Executive Vice President
Bijendra Malik
VP - Administration
Aruna Wickremeratne
VP - Bus. Development
Anand Tati
VP - General Counsel
Steven Sager
Browse more venture capital transactions:
Prev: 10/6/2018: Fusion Coolant Systems venture capital transaction
Next: 10/6/2018: Stay Alfred venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs